Physician profile
Eli Loch
NPI 1770711681
$2,196.16
in general payments reported to CMS, 2019-2025
23 companies · $802 in 2025
The $802 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $400 · 2020: $199 · 2021: $414 · 2022: $116 · 2023: $124 · 2024: $142 · 2025: $802.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,068.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,068.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $548.48 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, Bionic Navigator |
| Abbott Laboratories | $335.01 | 2021-2025 | Eterna |
| Curonix LLC | $196.96 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spr Therapeutics, INC | $145.06 | 2025 | Sprint Pns System |
| Vertos Medical, INC. | $123.34 | 2021 | |
| Bioventus LLC | $111.34 | 2019-2025 | |
| Abbvie INC. | $96.15 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $90.39 | 2019-2021 | |
| Saluda Medical Americas, INC. | $86.58 | 2025 | Evoke |
| Novartis Pharmaceuticals Corporation | $82.50 | 2019 | |
| Amgen INC. | $73.44 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $50.23 | 2019 | |
| Si-Bone, INC. | $41.14 | 2025 | |
| Idorsia Pharmaceuticals US INC | $29.99 | 2023 | Quviviq |
| Depuy Synthes Sales INC. | $29.45 | 2019-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $28.11 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.38 | 2019 | |
| Globus Medical, INC. | $23.31 | 2025 | Senza |
| Stimwave Technologies Incorporated | $18.66 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $18.22 | 2021 | |
| Biodelivery Sciences International, INC. | $16.50 | 2019 | |
| Medtronic, INC. | $14.43 | 2022 | |
| Zyla Life Sciences, INC. | $12.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eli Loch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.